Institutional Ownership Immix Biopharma, Inc. (IMMX)
This table provides information about the institutional ownership of Immix Biopharma, Inc. (IMMX). We have compiled data on the 34 institutions that hold shares in the stock, with a total of 3.15 Million shares, which have been reported (via 13F filing form) to have a value of $13.3 Million.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Snowden Capital Advisors LLC
New York, NY |
Nov 14, 2025 Q3 2025 |
10,000
shares
|
$42,100
0.0% of portfolio
|
Q3 2025
New holding
|
|
|
Mai Capital Management
|
Nov 10, 2025 Q3 2025 |
2,000
shares
|
$8,420
0.0% of portfolio
|
Q3 2025
New holding
|
|
|
Ubs Group Ag
|
Nov 13, 2025 Q3 2025 |
1,940
shares
|
$8,167
0.0% of portfolio
|
Q3 2025
Reduced 86.12%
|
|
|
Wells Fargo & Company
San Francisco, CA |
Nov 13, 2025 Q3 2025 |
330
shares
|
$1,389
0.0% of portfolio
|
Q2 2024
Reduced 23.96%
|
|
|
Northwestern Mutual Wealth Management CO
|
Nov 14, 2025 Q3 2025 |
80
shares
|
$336
0.0% of portfolio
|
Q1 2025
New holding
|
|
|
Citigroup Inc
|
Nov 10, 2025 Q3 2025 |
35
shares
|
$147
0.0% of portfolio
|
Q3 2025
New holding
|
|
|
Srs Capital Advisors, Inc.
Denver, CO |
Nov 14, 2025 Q3 2025 |
34
shares
|
$143
0.0% of portfolio
|
Q3 2025
New holding
|
|
|
Bank Of America Corp
Charlotte, NC |
Nov 14, 2025 Q3 2025 |
12
shares
|
$50
0.0% of portfolio
|
Q3 2025
Reduced 91.37%
|
|
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
Aug 12, 2025 Q2 2025 |
0
shares
|
$0
100.0% of portfolio
|
Q2 2025
New holding
|